Last update 08 May 2025

HTR3 x nAChRα1/β1/δ/γ

Basic Info

Related Targets
HTR3nAChRα1/β1/δ/γ

Related

1
Drugs associated with HTR3 x nAChRα1/β1/δ/γ
GYKI-46903
Target
HTR3 x nAChRα1/β1/δ/γ
Mechanism
5-HT3 receptor antagonists [+1]
Active Org.-
Originator Org.
Egis Gyógyszergyár Zrt.Egis Gyógyszergyár Zrt.
Active Indication-
Inactive Indication
Alzheimer Disease
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HTR3 x nAChRα1/β1/δ/γ
Login to view more data
100 Translational Medicine associated with HTR3 x nAChRα1/β1/δ/γ
Login to view more data
0 Patents (Medical) associated with HTR3 x nAChRα1/β1/δ/γ
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free